Vectans Pharma is a European-based pharmaceutical company with a primary focus to target unmet needs in patients with oral pathologies through the acquisition and worldwide commercial development of innovative targeted therapeutics.
Our current portfolio includes Sitavig® and Loramyc®, 2 products approved by FDA and several authorities in Europe, and 1 proprietary innovative galenic technology : Lauriad®.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.